Lilly’s weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea

By Bhanvi Satija (Reuters) -The U.S. Food and Drug Administration on Friday approved Eli Lilly’s weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug greenlighted to directly treat patients with the common sleeping disorder. The regulator approved the drug for moderate to severe obstructive sleep apnea in adults with obesity, the company…

Read More

Biden pushes out over $100 billion in clean energy grants as term winds down

By Valerie Volcovici WASHINGTON (Reuters) – U.S. President Joe Biden’s administration has awarded over $100 billion in grants created by its signature climate law, the Inflation Reduction Act, a senior administration official said. The administration hopes the spending milestone will help to continue the deployment of clean energy even after President-elect Donald Trump, a climate…

Read More